| Original language | English (US) |
|---|---|
| Pages (from-to) | 121-124 |
| Number of pages | 4 |
| Journal | Current Oncology |
| Volume | 20 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2013 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Oncology
Cite this
Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives : The Pan-Canadian Oncology Drug Review. / Hoch, Jeffrey S; Sabharwal, M.
In: Current Oncology, Vol. 20, No. 2, 2013, p. 121-124.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives
T2 - The Pan-Canadian Oncology Drug Review
AU - Hoch, Jeffrey S
AU - Sabharwal, M.
PY - 2013
Y1 - 2013
UR - http://www.scopus.com/inward/record.url?scp=84875874701&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875874701&partnerID=8YFLogxK
U2 - 10.3747/co.20.1315
DO - 10.3747/co.20.1315
M3 - Article
C2 - 23559876
AN - SCOPUS:84875874701
VL - 20
SP - 121
EP - 124
JO - Current Oncology
JF - Current Oncology
SN - 1198-0052
IS - 2
ER -